1-217064844-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_206594.3(ESRRG):​c.-224+24663G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 151,968 control chromosomes in the GnomAD database, including 11,312 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 11312 hom., cov: 32)

Consequence

ESRRG
NM_206594.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.369

Publications

7 publications found
Variant links:
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.677 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_206594.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESRRG
NM_001134285.3
c.-230+72823G>A
intron
N/ANP_001127757.1P62508-2
ESRRG
NM_001243509.2
c.-578+12008G>A
intron
N/ANP_001230438.1P62508-2
ESRRG
NM_001243510.3
c.-224+72823G>A
intron
N/ANP_001230439.1P62508-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESRRG
ENST00000359162.6
TSL:1
c.-106+24663G>A
intron
N/AENSP00000352077.2P62508-2
ESRRG
ENST00000366940.6
TSL:1
c.-230+72823G>A
intron
N/AENSP00000355907.2P62508-2
ESRRG
ENST00000493603.5
TSL:1
c.-224+72823G>A
intron
N/AENSP00000419594.1P62508-2

Frequencies

GnomAD3 genomes
AF:
0.372
AC:
56564
AN:
151852
Hom.:
11295
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.267
Gnomad AMI
AF:
0.492
Gnomad AMR
AF:
0.333
Gnomad ASJ
AF:
0.408
Gnomad EAS
AF:
0.694
Gnomad SAS
AF:
0.349
Gnomad FIN
AF:
0.395
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.417
Gnomad OTH
AF:
0.352
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.373
AC:
56628
AN:
151968
Hom.:
11312
Cov.:
32
AF XY:
0.371
AC XY:
27523
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.267
AC:
11088
AN:
41466
American (AMR)
AF:
0.333
AC:
5082
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.408
AC:
1415
AN:
3466
East Asian (EAS)
AF:
0.696
AC:
3596
AN:
5170
South Asian (SAS)
AF:
0.351
AC:
1689
AN:
4818
European-Finnish (FIN)
AF:
0.395
AC:
4158
AN:
10528
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.417
AC:
28329
AN:
67950
Other (OTH)
AF:
0.353
AC:
743
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1750
3501
5251
7002
8752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.404
Hom.:
34136
Bravo
AF:
0.367
Asia WGS
AF:
0.452
AC:
1568
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.6
DANN
Benign
0.55
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4537652; hg19: chr1-217238186; API